NOTCH signaling exerts essential roles in normal and malignant intestinal physiology and the homeostasis of cancer stem-like cells (CSC), but the basis for this latter role remains obscure. The signaling scaffold protein STRAP is upregulated in several cancers where it promotes tumorigenicity and metastasis. Here we report a novel oncogenic function for STRAP in maintaining CSC subpopulations in a heterogeneous mixture by antagonizing formation of the chromatin modifier PRC2 and by epigenetically activating NOTCH signals in human colorectal cancer (CRC). Silencing STRAP sensitized CRC cells to chemotherapeutic drugs in vitro and in vivo. STRAP depletion also contributed to a reduced stem-like phenotype of CRC cells, as indicated by reduced expression of the CSC signature and NOTCH signaling regulators in vitro and by diminished tumorigenesis in vivo. Genes encoding some upstream activators of NOTCH were highly enriched for H3K27me3, which form repressive chromatin domains upon STRAP silencing. Mechanistically, STRAP competitively disrupted association of the PRC2 subunits EZH2 and SUZ12, thereby inhibiting PRC2 assembly. Restoring the NOTCH pathway by lentiviral expression of NICD1 or HES1 in STRAP-depleted tumor cells reversed the CSC phenotype. In 90 CRC clinical specimens, a significant positive correlation was documented between the expression of STRAP and HES1. Overall, our findings illuminated a novel STRAP-NOTCH1-HES1 molecular axis as a CSC regulator in CRC, with potential implications to improve treatment of this disease.
disassembles the PRC2 complex by disrupting the interaction between SUZ12 and EZH2, resulting in the activation of NOTCH signaling via epigenetic modification. Importantly, clinical data show that the expression of STRAP is significantly correlated with HES1 expression. Together, our results provide a novel mechanism for the regulation of CSCs via STRAP/NOTCH1/HES1 regulatory axis.
MATERIALS AND METHODS

Cell culture and reagents
Human colon adenocarcinoma cell lines: HCT116, LoVo, SW620, DLD-1, WiDr, HT29 and RKO, and HEK-293T cells were purchased from the American Type Culture Collection (Manassas, VA). Cell lines were cultured in McCoy's 5A medium with 10% of FBS; and HEK-293T cells were maintained in DMEM medium with 10% of FBS. 5-FU (F6627) and Oxaliplatin (O9512) were obtained from Sigma Aldrich.
Adenoviral and lentiviral transduction
STRAP-expressing adenovirus was used as we described previously (13) . Lentivirus constructs containing NICD1 and HES1 were obtained from Dr. Matthew Walters (Weill Cornell Medical College) and Dr. Linzhao Chang (Johns Hopkins University), respectively. STRAP shRNA lentivirus was produced as described (13) . Lentivirus shRNA targeting SUZ12 was purchased from Sigma Aldrich.
AOM/DSS treatment of Strap +/mice
Heterozygous knockout mice were generated using ZFN technology (20) Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
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For immunohistochemical (IHC) analyses, paraffin-embedded tissues were incubated with the indicated antibodies. The proportion score represents the estimated fraction of stained cells (0 = 0%, 1 = 1%-24%, 2 = 25%-49%, 3 = 50%-74%, and 4 = 75%-100%), while the intensity score represents their average staining intensity (0=no staining, 1=weak staining, 2=moderate staining, and 3=strong staining). The final staining score was determined by multiplying the intensity score by the proportion score.
As a result, scoring was between 0 and 12.
qPCR and ChIP assays qPCR analysis was performed as described previously (18) . Purification of sonicated nuclear lysates and immunoprecipitation were performed using an EZ-ChIP assay kit (Upstate Biotechnology). The DNA samples recovered from the ChIP were analyzed by quantitative PCR using specific primers ( Supplementary Table S1 ). Primers targeting 84 genes key to NOTCH signaling pathway were provided by the EpiTect ChIP qPCR Array kit (QIAGEN).
Co-immunoprecipitation (co-IP) and western blot
Co-IP and western blot assays were performed as described previously (18) . Primary antibodies included: CD133 (18470-1-AP) (Proteintech Group); ABCG2 (sc-25822), HA (sc-805) (Santa Cruz Biotechnology); CD44 (#558739) and STRAP (#611346) (BD Transduction Labs); Cleaved Caspase 3 (#9661), Cleaved NOTCH1 (#4147), DLL1 (#2588), DLL4 (#2589), NUMB (#2756), TACE (#6978), JAG1 (#2620), JAG2 (#2210), HES1 (#11988), OCT4 (#2840), SNAIL (#3879), SLUG (#9585) and BMI1 (#5856) (Cell Signaling Technology); Tri-Methyl-Histone H3 (Lys27) (ab192985), SUZ12 (ab12073), EZH2 (ab3748), EED (ab169647) (Abcam); and β-actin (A5316) and Flag (F3165) (Sigma). More details are in Supplementary Information.
Statistical analyses
All values in the figures and text were derived from at least 3 independent experiments and expressed as means ±SD. Statistical analyses were completed using the SPSS statistical software package (SPSS/PC+, SPSS Inc.). Significant differences in mean values were evaluated by the student's t-test. A two-sided P <0.05 was considered statistically significant.
Results
Reduced expression of STRAP enhances drug-induced apoptosis and sensitizes colorectal cancer cells to chemotherapy
Prompted by our previous studies pointing to a potential oncogenic role of STRAP (13, 14) , we hypothesized that STRAP may play an important role in drug responses in CRC. MTT assays were performed to evaluate the effect of 5-FU or Oxaliplatin on the survival of human CRC lines, HCT116 and DLD-1 at 72h posttreatment. We first knocked down (KD) STRAP expression with two independent STRAP shRNAs (shSTRAP#1 and shSTRAP#2) in these cell lines ( Supplementary Fig.   S1A ). The shSTRAP#1 clone displayed more sensitivity to 5-FU and Oxaliplatin, indicated by the lower IC 50 values as compared to those of the shCtrl clone ( Supplementary Fig. S1B and C). After treatment, the percentage of apoptotic cells in STRAP-depleted HCT116 clone was dramatically increased in response to 5-FU or Oxaliplatin (10.0% to 23% or 20.5% to 32.2.5%, respectively) as compared to the shCtrl clone ( Fig. 1A , upper panel). An increase in apoptosis was also observed in STRAP knockdown DLD-1 cells relative to control cells (8.5% to 18.3% with 5-FU; 14.4% to 25.8% with Oxaliplatin) (Fig. 1A , bottom panel). Interestingly, we did not observe much effect of STRAP knockdown in both cell lines without drug treatment. In an attempt to understand the mechanism, we observed an increase in cleaved caspase-3 activity in HCT116 and DLD-1 STRAP-depleted cells ( Fig. 1B) with the same treatment. Taken together, these data suggest that loss of STRAP enhances 5-FU and Oxaliplatininduced apoptosis and sensitizes CRC cells to these drugs.
To investigate the effect of downregulation of STRAP on drug sensitivity in vivo, we treated mice bearing subcutaneous tumors generated from shCtrl and shSTRAP#1 clonal cells with 5-FU or Oxaliplatin. Knockdown of STRAP alone had a significantly slower rate of growth of HCT116-derived tumors as compared to control (Fig. 1C) bearing tumors from STRAP knockdown HCT116 clone showed significant sensitivity to 5-FU or Oxaliplatin when compared with those from shCtrl clone (Fig. 1C) . Similarly, we observed that knockdown of STRAP in DLD-1 cells induced sensitization to Oxaliplatin treatment compared to the corresponding control clone (Fig. 1D ). Apoptosis analyzed by active caspase-3 staining was significantly increased in 5-FU treated shSTRAP#1 tumors relative to its parallel group ( Fig. 1E and Supplementary Figure   S1D ). In contrast, less staining of the proliferation marker Ki67 was observed in both untreated and treated shSTRAP#1 tumors relative to their corresponding controls ( Fig.   1E and Supplementary Figure S1D ). These results provide evidence that reduced expression of STRAP potentially promotes the sensitivity of CRC cells to 5-FU or Oxaliplatin-based chemotherapy.
Due to potential contributions of CSCs in drug resistance, we reasoned that STRAP may be involved in drug resistance through regulating CSCs. To assess this, we first analyzed the expressions of STRAP and CSC markers/regulators in 193 patient samples using TCGA mRNA-seq colon adenocarcinoma dataset. Linear regression analyses showed that STRAP expression is significantly positively correlated with the mRNA expressions of BMI1, CD24, CD44, EPCAM, ITGB1 (CD29), and PSEN1 (P<0.0001, Fig. 1F ). These genes have been proposed for the identification of colorectal cancer stem-like cells (21) . The upregulation of these markers is significantly correlated with invasion and metastases, and they are associated with poor prognosis (22) (23) (24) .
These analyses in conjunction with our above observations suggest that STRAP might play an important role in drug responses through regulating stemness of human CRC tumors.
STRAP is important in maintaining the homeostasis of colorectal cancer stem-like cell pool
To explore the potential effect of STRAP on CSCs, flow cytometry was employed to estimate the percentage of cells co-expressing CD44 and CD133 in six CRC cell lines. Expression of STRAP in each cell line after its knockdown was detected by western blot assays ( Supplementary Fig. S1E ). Despite differences in the genetic profiles of the cell lines, significant reduced expression of CD44/CD133 was observed in all shSTRAP clones (shSTRAP#1 and #2) compared to their control counterparts ( Fig.   2A , Supplementary Fig.S2A ). These data suggest that loss of STRAP could partly diminish the CD44+/CD133+ subpopulation in the heterogenous mixture of cells. The next set of experiments carried out were tumor sphere assays to determine whether STRAP might regulate the self-renewal behavior of CSCs. The number of spheres in STRAP KD HCT116 and DLD-1 cells was found to be >2-fold less than those formed in the control cells (P<0.01, Fig. 2B and C). Furthermore, the average diameter of spheres obtained from STRAP KD cells was much less than that of control cells. It is worth noting that downregulation of STRAP almost eliminated the spheres with size >200um in both cell lines, indicating that STRAP participates into the proliferation of CSCs.
Colony formation assays showed that KD cells have less proliferation potency in the anchorage-independent condition ( Fig. 2D ). To further ascertain that STRAP could functionally mediate the stemness of CSCs, we increased the levels of STRAP by infecting cells with adenovirus-containing STRAP. Following the overexpression in two cell lines, there was a marked increase in sphere number and size, compared to the corresponding ß-gal control cells (P<0.01, Fig. 2E ).
To evaluate the effect of STRAP on tumor stem-like cells in vivo, we employed Strap +/mouse model and induced tumorigenicity in the colon with the carcinogen, azoxymethane (AOM) and with the inflammatory agent, dextran sodium sulphate (DSS).
Heterozygous deletion of Strap markedly inhibited tumor growth in mice (Fig. 2F and G).
We routinely observed a decrease in STRAP expression in the intestine and colon of heterozygous mice by 60-70% ( Fig. 2H ). As reported (25) , histologically a majority of carcinomas were observed and no metastatic lesion was evident after 10 weeks of AOM/DSS treatment ( Supplementary Fig. 2B ). Immunohistochemical staining showed that nuclear staining of Ki67, a proliferative marker (26) , was significantly decreased in colon tumors of Strap+/-mice compared to those in the wild type animals, indicating STRAP deficiency inhibits colon carcinogenesis in mice ( Fig. 2I ). Interestingly, we observed less expression of CD44 and CD133 in tumors generated from Strap+/-mice ( Fig. 2I ), further supporting our observations in human cell lines. Therefore, these findings suggest that STRAP is involved in CSC homeostasis and loss of STRAP results in lower proportion of CSCs.
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STRAP regulates the expression of a specific subset of NOTCH signaling effectors
To understand the mechanism of STRAP-induced regulation of cancer cell stemness, we assessed the expression of diverse sets of genes: common stemness regulators such as OCT4, SOX2, NANOG, and BMI1; Zinc-finger transcription factors including SNAIL, SLUG and TWIST; and CSC surface markers like CD44, CD133 and ABCG2. qPCR data revealed that SOX2, OCT4, BMI1, CD133, and CD44 were significantly reduced in different cell types after STRAP KD ( Supplementary Fig S3A) , suggesting the deregulation of stemness-related genes by STRAP in a contextdependent manner. Western blot assays confirmed that downregulation of STRAP was able to reduce the expression of the above markers in a cell-type specific manner ( Fig.   3A ). Immunofluorescence staining showed lower expression of SOX2 and NANOG in STRAP KD cells when compared to control cells ( Fig. 3B and C). It has been reported that activated NOTCH signaling promotes the self-renewal capacity of colorectal CSCs (10) . Here, we hypothesize that STRAP might participate in the activation of NOTCH signaling and modulates the molecular signature of CRC stem-like cells. To this end, we first detected a series of genes by qPCR, including four NOTCH receptors (NOTCH 1-4) and five ligands (DLL-1, -3, -4, JAG-1 and -2), as well as their well-documented target genes (HES1/5, HEY1/2, NRARP, and DTX) (27) (28) (29) . mRNA levels of JAG2, HES1 and HES5 were significantly downregulated in both KD clones as compared to their control counterparts ( Fig. 3D ). In addition, shSTRAP HCT116 clones showed reduced NOTCH1 and HEY1, and DLD-1 clones showed reduced DTX1 expression ( Fig. 3D ). Notably, NOTCH1 intracellular domain (NICD1), HES1 and JAG2 proteins were lower in shSTRAP clones as compared to the corresponding control cells ( Fig. 3E and Supplementary Fig. S3B ). On the contrary, there were no changes in the of STRAP, which is reversed by re-expression of adenoviral STRAP in both cell lines ( Fig. 3F ). Next, we investigated whether intrinsic NOTCH signaling could be inhibited through the loss of endogenous STRAP expression. Luciferase assays showed the inhibition of HES1 and HES5 promoter activity mediated by reduced level of STRAP ( Fig. 3G ). These results suggest STRAP involvement in the control of stemness regulators/markers in CRC cells, likely through activation of NOTCH pathway.
STRAP helps to maintain the patterns of histone modification signature on NOTCH genes
Cumulating evidence suggests that histone modifications play a pivotal role in regulating transcriptional activity of NOTCH-related genes (30) . We performed chromatin immunoprecipitation (ChIP) with anti-Histone H3K4me3 and H3K27me3 antibodies followed by qPCR analyses using shCtrl and shSTRAP#1 clones in HCT116 cells. The histone modification patterns for a set of genes involved in NOTCH signaling are represented as a heat map ( Fig. 4A) . We obtained 29 genes with low levels of H3K4me3 and 54 genes with H3K27me3 enrichment at the proximal promoter region ( Fig. 4B ). Bivalent domains bound by both H3K4me3 and H3K27me3 are found in some transcriptionally repressive genes (31) . Therefore, we chose a total of 22 genes featured by increased H3K27me3 and reduced H3K4me3 levels with significant pvalues (Supplementary Table 2 ), and we performed ChIP-qPCR ( Supplementary Fig.   4 ). Upon depletion of STRAP, the transcripts of 14 and 11 genes were downregulated in HCT116 and DLD-1 cells, respectively ( Supplementary Table 3 ). Collectively, these results indicate that the epigenetic status of NOTCH effectors and targets could be impaired by downregulation of STRAP.
STRAP dissociates polycomb repressive complex 2 (PRC2) via competitive binding with SUZ12
We observed that loss of STRAP led to a remarkable distribution of H3K27me3 on the loci of NOTCH genes. We then questioned whether the global levels of H3K27me3 could also be affected by STRAP, in addition to its bias on the accessibility of target gene loci. Western blot assay revealed that the total protein levels of and Supplementary Figure S5A ). In contrast, there is no effect of STRAP on the levels of two key subunits of PRC2 complex, SUZ12 and EZH2 ( Fig. 4C and Supplementary   Figure S5A ), indicating that STRAP may structurally deregulate this complex function without disrupting its subunit expression. Therefore, we were prompted to examine the possible inhibitory effect of STRAP on PRC2 complex, which has an established role in trimethylating H3K27. Co-immunoprecipitation (co-IP) after co-expression of the tagged proteins in 293T cells showed that HA-tagged SUZ12 was detected in the anti-Flag immunoprecipitates. Reciprocally, Flag-tagged STRAP was also co-immunoprecipitated by the anti-HA antibody (Fig. 4D) . In contrast, HA-EZH2 and HA-EED were not observed in the STRAP immunoprecipitates ( Supplementary Figure S5B and C) . These results suggest that there is a specific interaction between STRAP and SUZ12, despite STRAP not being incorporated into a complete PRC2 complex. Indeed, endogenous STRAP protein was also co-immunoprecipitated by anti-SUZ12 antibody from HCT116 and DLD-1 cells (Fig. 4E ). However, we did not observe any endogenous interaction of STRAP with either EZH2 or EED (data not shown) as mentioned above. Together, the data suggest that STRAP selectively interacts with SUZ12, and not with EZH2 and EED.
The interaction between STRAP and SUZ12 led us to examine if STRAP affects the PRC2 complex assembly. We co-expressed proteins by co-transfecting HA tagged-EZH2 and -SUZ12 together with dose-dependent Flag-tagged STRAP. As expected, SUZ12 was co-immunoprecipitated by anti-EZH2 antibody. Interestingly, increasing STRAP overexpression greatly decreased the SUZ12 and EZH2 complex formation with no change in their protein levels (Fig. 4F) . In contrast, there was no altered interaction between EZH2 and EED upon increased STRAP expression ( Fig. 4G ). To further assess whether depletion of STRAP-induced reduction in HES1 depends on SUZ12, endogenous expression of HES1 was tested by a specific shSUZ12 RNA. Western blot assay showed that SUZ12 KD had a positive effect on HES1, as evidenced by a significantly increased level of HES1 in shSUZ12 cells compared to that in scramble shRNA cells (Fig. 4H ). Furthermore, restored expression of HES1 was observed in STRAP KD cells with concomitant loss of SUZ12 (Fig. 4H) Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
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Loss of STRAP expression enhances PRC2 trimethyltransferase function on H3K27 at HES1 and HES5 loci
To address the functional regulation on local chromatin modification of target genes in CSCs by STRAP, we extended our studies to sphere-derived cells, which have more cancer stem-like properties than cells in adherent culture system (32) . We first validated that sphere-derived cells are suitable for CSC model, based on significant enrichment of CD133+/CD44+ cells. Enrichment was accompanied by enhanced activation of NOTCH signaling, with increased expression of JAG receptors and HES1 ( Fig. 5A and B) . Surprisingly, increased expression of STRAP was observed in sphere culture condition, especially in HCT116 and DLD-1 cells, suggesting a potential involvement of STRAP in CSC maintenance (Fig. 5B ). Next, we stably knocked-down STRAP using lentivirus-mediated shRNA#1 in HCT116 and DLD-1 sphere derived-cells ( Fig. 5C ). qPCR assay showed a significant decrease in CD133, CD44, HES1, and HES5 in KD HCT116 cells and CD133, CD44, and HES1 in KD DLD-1 cells (Supplementary Figure S6) . To closely examine the chromatin signature of STRAP target genes in these cells, two transcription factors activated by NOTCH signaling, HES1 and HES5, were chosen to perform ChIP assay (Fig. 5D ). H3K27me3 is highly distributed at several binding sites on the target genes along more than 3.0 kb upstream of TSS in KD sphere-derived cells; whereas H3K4me3 showed a decreased abundance at the same sites ( Fig. 5D-F) . These results indicate that the two markers compete with each other to occupy the loci of HES1 and HES5, and the inactive chromatin status is controlled by H3K27me3 upon STRAP downregulation. Of note, concurrence of EZH2 and SUZ12 enrichment with H3K27me3 abundances was also observed in most target binding regions ( Fig. 5E and F) , further evidencing the pattern of H3K27 trimethylation on its target cis-regulatory regions. Next, we conducted gain-of-function assays either with NICD1-or with HES1lentiviral constructs to re-activate NOTCH signaling in STRAP-KD cells. Restoration of NICD1 or HES1 resulted in significantly increased mRNA levels of NOTCH target genes (e.g. HES1, HES5, and TWIST), CD133, and CD44 in a cell-dependent manner (Fig. 6A and B), suggesting that NOTCH signaling is important in STRAP-mediated regulation of stemness-related genes. Western blot assays further confirmed the restored protein expressions of CD44, CD133, and HES1 by either NICD1 or HES1 in STRAP KD cells (Fig. 6C) . The differential expression of CD44 and CD133 in different cell lines at mRNA and/or protein level regulated by STRAP may take place through different mechanisms. The percentage of CD44+/CD133+ cells was significantly increased in response to NICD1-or HES1-restoration in shSTRAP cells relative to β-gal control cells ( Fig. 6D) . To address the concurrent biological outcomes, we compared the proliferative ability of the rescued cells with corresponding STRAP-KD cells. Both NICD-1-and HES1-rescued cells showed the restoration in spheroid number and size compared to the STRAP-KD groups (Fig. 6E and F) . Collectively, our data suggest that activation of STRAP-induced NOTCH signaling is involved in promoting stem-like phenotype of CRC cells.
NICD1-HES1 signaling restores the stem-like phenotype of CSCs in STRAP KD cells
STRAP positively correlates with the expression of HES1 in human CRC
To verify the biological significance of NOTCH signaling activation by STRAP, we examined the correlation of expression between STRAP and HES1 in human CRC. We performed immunohistochemical analyses for STRAP and HES1 in serial sections of colon tumor microarrays (TMA) containing 90 CRC patient specimens. The results showed that HES1 and STRAP are both upregulated in the colon cancer tissues compared with normal colon tissues with values 72.5% and 65.3%, respectively ( Fig.   7A-D) . We also observed that the higher score of HES1 is concomitant with that of STRAP (IHC score from 6 to 12) compared to the low expression group (IHC score from 0 to 4) (7.21 versus 3.24) (Fig. 7E, F and G) . A statistically significant positive correlation was observed between the expressions of STRAP and HES1 in adenocarcinoma samples (Fig. 7H) . Consistent with previous observations, STRAP and HES1 have been found to be present in both the nucleus and cytoplasm. Moreover, we found that the expression of both STRAP and HES1 was much higher in AJCC stage I than that in other stages ( Fig. 7E and F ), suggesting that STRAP and HES1 may coordinately function in CRC tumorigenesis. This observation is also consistent with previous studies showing that NOTCH signaling is high in early stages of human CRC (33) . To further assess the clinical relevance of STRAP expression, TCGA data of 274 colorectal adenocarcinoma (COAD) patients and 41 controls were downloaded from UALCAN: http://ualcan.path.uab.edu/index.html (34) . The mRNA level of STRAP was increased in all stages of colorectal cancer tissues compared to the normal tissues (Fig.   7I ). The overall survival of CRC patients was significantly associated with STRAP expression (P<0.05) (Fig. 7J) . The prognosis of patients with high STRAP expression was worse than cases with low expression. Taken together, these data indicate that STRAP-induced activation of NOTCH signaling is involved in colorectal cancer progression and in maintaining cancer stem-like subpopulation.
Discussion
In this study, we observed the variation of CSC markers based on tumor cell types and this subpopulation constitutes 0.1-10% (35, 36) . It is important to note that the best marker/s to identify CRC CSCs is not well-defined thus far. However, the expression of putative markers for CRC CSCs, like CD133 and CD44, are positively regulated by STRAP in a number cell types ( Fig. 2A) . This is supported by the result that knockdown of STRAP reduced the expression of some stem cell markers that are more frequently found in poorly differentiated tumors with poor clinical outcome ( Fig.   3A -C) (37, 38) . Notably, mRNA of CD133 was rescued in HCT116 KD cells, and mRNA of CD44 was rescued in DLD-1 KD cells by NOTCH signaling. However, protein levels of CD133 and CD44 were up-regulated in both STRAP KD cell lines ( Fig. 6A-C ), suggesting the involvement of a different mechanism. The role of STRAP in regulating these stem-related markers is also supported by in vivo data using heterozygous mice ( Fig. 2G-I) .
JAG/NOTCH/HES signaling has been implicated in the regulation of cell proliferation, EMT, metastasis, stem-like phenotype, and chemoresistance. We have shown that STRAP-mediated activation of JAG2, NOTCH1, HES1, and HES5 plays an important role in CRC tumorigenicity and stemness (Fig. 3D, E, and Fig. 6 ). This is Research.
Author Manuscript Published OnlineFirst on August 21, 2017; DOI: 10.1158/0008-5472. confirmed by the restoration of stemness markers and phenotype by the expresion of NICD1 or HES1 in STRAP knockdown HCT116 and DLD-1 clones (Fig. 6) . As a result, STRAP KD cells are much less aggressive in terms of soft agar colony formation and sphere formation (Fig 2B-E) . Our future work will determine whether other cytokines, chemokines, and environmental alterations functionally interact with the activation of intrinsic NOTCH signaling activated by STRAP.
Our data show that the protein level of STRAP is highest in stage I and its expression is lower but similar in the stages II/III/IV. However, all stage levels are significantly higher compared to levels in normal tissues ( Fig 7E) . The mRNA level of STRAP was increased in all stages of CRC tissues compared to normal tissues (Fig.   7I ). Our data support the roles of STRAP in promoting cancer cell stem-like phenotype and in drug resistance. These observations are in agreement with a previous report that CRC patients with upregulation of STRAP had worse survival with adjuvant therapy, suggesting its vital role in chemoresistance (39) . The level of STRAP did not increase in advanced stages (III/IV) from stage I, and it promotes cell proliferation in vivo ( Fig. 1E and 2I). It has been shown that in advanced stages of CRC patients, tumor cells exhibit a decreased cell proliferation that might reduce the effectiveness of chemotherapeutics, such as 5-FU and Oxaliplatin, which primarily target rapidly-dividing cell populations (40) . A medium level of STRAP expression (not high) in advanced stages may contribute to low level of cell proliferation, a factor important for resistance to cytotoxic drugs. In addition, the highest expression of STRAP in stage I may be involved in tumor progression. A similar expression pattern has been observed for another protein ZBP-89 that plays an important role in CRC progression and maintenance of cancer cell stemness (41) . Together, high expression of STRAP in different stages of CRC may be linked to tumor progression and stemness phenotype.
Loss of PRC2 function contributes to oncogenesis in leukemia and lymphoma,
indicating the component genes of PRC2 serve as tumor suppressors (42, 43) . On the other hand, abnormal expressions of PRC2 genes correspond to human epithelial tumors (44, 45) . Although the H3K27me3 level is not always sufficient to prevent transcriptional activation (46) , PRC2-mediated H3K27 tri-methylation is found remarkably in the promoter regions of inactive transcripts of NOTCH genes in STRAP Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on August 21, 2017; DOI: 10.1158/0008-5472.CAN-17-0286 KD cells. These results point to a critical role of STRAP as a positive modulator of NOTCH signaling by effectively repressing the formation of PRC2 complex in CSCs ( Fig. 7K) . Therefore, our data provide evidence, for the first time, that 1) key components of PRC2 are necessary to selectively inactivate the transcription of NOTCH target genes in STRAP KD cells; 2) upregulation of STRAP in CRC impairs the association of the complex and influences H3K27me3, a hallmark for the repression of NOTCH related genes; and 3) EZH2 and SUZ12 might be the putative tumor suppressors in our models, depending on their activated function on target chromatin regions rather than the deregulated expression.
In conclusion, we show that STRAP exhibits oncogenic effects through mediating the epigenetic activation of NOTCH signaling, and is a regulator of tumor stemness behavior and drug response. In addition, the significant correlation of the expression of STRAP with HES1 and with stem markers in CRC patients highlights its clinical importance for novel therapeutic options in CRC treatment. 
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